Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 48 out of 100. Clinical safety

Topic: Risk, prevention and care in population studies

Plain-language summary

The control cohort (n = 36.5 million) was 1:1 PSM for age and sex with the HL cohort (n = 1.77 million) in which 0.28% of patients developed delirium compared to 0.74% in the HL cohort (OR 2.66, 95% CI = 2.58-2.75). When looking at the same PSM between HL and implantable device cohorts (n = 20,847), 0.81% developed a delirium diagnosis compared to 0.45% in the implantable device cohort (OR = 1.79, 95% CI = 1.39-2.31). Further analysis accounting for 16 PSM covariates showed that 0.74% of the HL cohort developed delirium compared to 0.45% of the implantable device cohort (OR = 1.64, 95% CI = 1.27-2.13). The present study shows that patients with hearing loss were more likely to develop delirium than those with normal hearing. Importantly, patients with implantable hearing devices were significantly less likely to develop delirium compared to hearing loss patients without an implantable device. Our research highlights the importance of treating hearing loss to prevent delirium.Level of Evidence: III.

What this study adds

Evidence grade: Moderate

The record lists 36 participants. It is about treating hearing loss to prevent delirium, not about treating, curing or preventing Alzheimer's disease. Reported effect size: 0.28%; 0.74%; OR 2.66.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Hambach, B., Patel, J., Nunes, K. L., Sina, E. M., Llerena, P., Knops, A. M., et al. (2025). Impact of Implantable Hearing Devices on Delirium Risk in Patients with Hearing Loss: A National Database Study. Otology & Neurotology. https://doi.org/10.1097/mao.0000000000004416

Vancouver

Hambach B, Patel J, Nunes KL, Sina EM, Llerena P, Knops AM, et al. Impact of Implantable Hearing Devices on Delirium Risk in Patients with Hearing Loss: A National Database Study. Otology & Neurotology. 2025. doi:10.1097/mao.0000000000004416. PMID: 40059784.

BibTeX

@article{hambach2025-40059784,
  author  = {Hambach, Bryce and Patel, Jena and Nunes, Kathryn L. and Sina, Elliott M. and Llerena, Pablo and Knops, Alexander M. and Chiffer, Rebecca C. and Hunter, Jacob B.},
  title   = {{Impact of Implantable Hearing Devices on Delirium Risk in Patients with Hearing Loss: A National Database Study}},
  journal = {Otology \& Neurotology},
  year    = {2025},
  doi     = {10.1097/mao.0000000000004416},
  pmid    = {40059784},
  url     = {https://doi.org/10.1097/mao.0000000000004416}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This national database study found that patients with hearing loss were more likely to develop delirium than those with normal hearing, and that patients with implantable hearing devices were significantly less likely to develop delirium than hearing loss patients without an implantable device. It is about treating hearing loss to prevent delirium, not about treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 48/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 1 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 48 of 100.48 of 100 points earned52 not earned

Published in a peer-reviewed journal, and it is a retrospective cohort study, reconstructed from past records. Scored zero for randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Otology & Neurotology)
Journal's citation record 1 / 4 Otology & Neurotology: journal h-index 142 (OpenAlex, 2026-10-29)
Study design 7 / 12 A retrospective cohort study, reconstructed from past records
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 1 / 4 36 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 2 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.7 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Jacob B. Hunter: h-index 29 (OpenAlex, whole career)
Institution's track record 1 / 3 Thomas Jefferson University: institution h-index 825 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40059784)
Free to read 0 / 2 Behind a paywall — scores zero
Total 48 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Clinical safety from nearby years

Also tagged “palliative”

858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Clinical safety

See all studies in Clinical safety →